Sign in
CompletedPhase 3

7 Days vs. 14 Days of Vonoprazan-based Triple Therapy for H. Pylori Eradication

Key facts

Who runs it
Alexandria University
Where
Egypt1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
Phase
Phase 3
People taking part
326 people enrolled
Started
30 Jun 2024
Ended
1 Dec 2024
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Vonoprazan
  • Amoxicillin
  • Clarithromycin
Record updated
11 February 2025

Who can take part

Age
10 years to 18 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Participants in the age group (10-18 years), both genders, referred with dyspeptic complaints such as heartburn, dyspepsia, nausea, and epigastric pain who are positive for H. Pylori infection by a standardized diagnostic test
  • Pediatric patients with a clinical, laboratory, and endoscopic diagnosis of H.P.-positive gastritis and the other conditions necessary for H.P. eradication, according to the Maastricht V consensus report

Who cannot take part

  • previous attempts to eradicate H.P
  • allergy to any of the drugs used in the study
  • Children with the diagnosis of any condition that might affect the absorption of drugs such as celiac disease or Crohn's disease
  • hepatic impairment or kidney failure
  • symptoms suggestive of functional disorders
  • receipt of antibiotics, PPIs, bismuth, H2 antagonists or probiotics within 4 weeks of the study

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The study aims to test the efficacy of 7 days vs. 14 days of Vonoprazan-triple therapy in the eradication of Helicobacter Pylori infection in adolescents and young children.

The 2 groups in the trial

  • 14-days Vonoprazan-based triple therapyExisting treatment, for comparison

    Vonoprazan tablets 20 mg twice daily plus Amoxicillin 50 mg/kg/day capsules or suspension \[maximum daily dose 2 g\] plus Clarithromycin 20 mg/kg/day tablets or suspension \[maximum daily dose 1 g\]. The triple combination will be given for 14 days .

    Treatment: Vonoprazan, Amoxicillin, and Clarithromycin

  • 7-days Vonoprazan-based triple therapyTreatment being tested

    Vonoprazan tablets 20 mg twice daily plus Amoxicillin 50 mg/kg/day capsules or suspension \[maximum daily dose 2 g\] plus Clarithromycin 20 mg/kg/day tablets or suspension \[maximum daily dose 1 g\]. The triple combination will be given for 7 days.

    Treatment: Vonoprazan, Amoxicillin, and Clarithromycin

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
7-day Versus 14-day Vonoprazan-based Triple Therapy for Eradication of H. Pylori in Adolescents: A Randomized Controlled Trial
Record updated
11 February 2025